-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BIF83cvX7FuZFimRmQQrLGgnkGudF+m6ZBjJN4k6KtF140Ky+EMnWAIPmhLpIPpp IDBO2SCk+plXz8X2QUSt4Q== 9999999997-09-026563.txt : 20091116 9999999997-09-026563.hdr.sgml : 20091116 20091116143007 ACCESSION NUMBER: 9999999997-09-026563 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20091116 DATE AS OF CHANGE: 20091116 20091116 20091116 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 091185720 BUSINESS ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C0-)>+CS],-"C8@,"!O8FH-/#PO3&EN96%R:7IE9"`Q+TP@.#`P M-"]/(#@O12`S-SDP+TX@,2]4(#!F\W!8WW@HFO:K`9@$:`Z M/B.H/BL@9F5@D&6#B#-\`@@P`$>#!ST-"F5N9'-T7!E+T-A=&%L M;V7!E+U!A9V4^/@UE;F1O8FH-.2`P(&]B:@T\/"]&;VYT/#PO5%0R(#$P M(#`@4B]45#0@,3(@,"!2/CXO4')O8U-E=%LO4$1&+U1E>'1=+T5X=$=3=&%T M93P\+T=3,2`Q-2`P(%(^/CX^#65N9&]B:@TQ,"`P(&]B:@T\/"]3=6)T>7!E M+U1R=654>7!E+T9O;G1$97-C7!E+T9O;G0^/@UE;F1O M8FH-,3$@,"!O8FH-/#PO3&5N9W1H(#$S,3(O1FEL=&5R+T9L871E1&5C;V1E M/CYS=')E86T-"FC>?%99;^,V$'[WKQB@+V1A<27JLO;-\9%UL7&VL0(4:(I" MMIF8A2QY=6R2?]_A(?G*KH/80XIS??/-4)]N5QZ\U(.;=/`I33EXD#X//`XN M_N%/XD+LCM@H@'0_<.$%_].-^GH=$*#I?P-O!(['O!#2J=U)?[\4')\EH_!X MSF&NBWIHR`JO@[_)XW*1SJ@3L!&9PHHZ(8M(2ADGX]3LSE9`_TG_&#@1BT?G MQMS(&E.",K::31X?%NF"XN%`:8Z74T#K/AK]:_)EO+RU"YCFTN=4.N=%>3&>H,?X*Z<-L MG-[APL*%BE%XG9+!7'E,O\R@`PRAFEF`8#Q)X7X.7N*K:G`26(,ABX/PY[EZ M/O.C$U)\FWZ%&UE^VV75/AO"HM@P"U@47'('RQ6>;LYE+F!9,L"8'2^)0S0, MD_EO/.#<-=X83TX4_OWHHP\BNP/#;H5(;!((CJ[=BIB%IJ"*G+%Z4&8TZ-I,*QN_"4I$BXN*M$46MS);/D,&A$C]DV=;P4F6% MAL=COA\:VBBMH[YOTFI0$6/S"6S*@D8HF*7XXY&.L";F MLW+XE^5H=@)F;SNYEDT-38FYSTM=$#3CNEV?>N=,N,EJXZ$2B'N-<.BD:UB_@V$)=6*%CN%*C-EF M0^V,8X:C8U&"+CD_L!XTH9I=UN"7K!6N"%"@<0Z(1IA;A+^W62[-4REJBZ"Q M_Q,`;>&S6E7\V=8YQ\7>X".JC5J7%4)89(5>F`F$&'I'+IFAZYQ,75O^$<9B M@FLURU6IYI40V](\4U1=7!ZUI3B!@_C?L*BDE9'-LA;8(`Q@;$YLRFJ++8_] M$I.*3<:]"ZP_B5Y^6K&CU"M9?6QC9^E7G>91Y?WY$]A5U-8:*@6@OLC%SH+D'8 ME!>+AQE,/#R)/^P-A+8'D"!:IY$J=FQ9/2_@("I9;J$^B(U\EF+[^3@U>/B+ M:\G,]Z"/6+,*+X(@L8`!=`,%J.YOS\4KG7I)$!(,I"K;EYU]/W<9 M?3!&KX4.#PT[?KXI"#TUU5`(?+P0]VHG1D&H'7P%Q9Y`0>UDW8X%_HOZX:A< MFO5KM[Y6[85^ZG<1K+H(#L9(K[OI!'GE_\2:UIEHQUT8K?H)26%6M3J;?!C4 M^0WT,]1FZ>!_`08`1N+9PPH-"F5N9'-T2A4:6UE2A4:6UE7!E+T5X=$=3=&%T92]302!F86QS92]332`P+C`R M/CX-96YD;V)J#3$@,"!O8FH-/#PO3G5MFMC M.60B/SX*/'@Z>&UP;65T82!X;6QN#IX M;7!T:STB061O8F4@6$U0($-O&UL;G,Z9&,](FAT='`Z+R]P=7)L+F]R9R]D8R]E;&5M M96YT"UD969A=6QT(CY-:6-R;W-O9G0@5V]R9"`M(%!$3"!":6]0:&%R;6$@26YC M+B!/&%P34TZ26YS=&%N8V5)1#YU=6ED.CAC,C-A,C`W M+3)F,S`M-#EF-2TX8C`X+30P.&,R-F4T938R93PO>&%P34TZ26YS=&%N8V5) M1#X*("`@("`@/"]R9&8Z1&5S8W)I<'1I;VX^"B`@(#PO -----END PRIVACY-ENHANCED MESSAGE-----